Northwest Biotherapeutics Inc

General ticker "NWBO" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $347.3M

Northwest Biotherapeutics Inc does not follow the US Stock Market performance with the rate: -39.7%.

Estimated limits based on current volatility of 3.6%: low 0.25$, high 0.27$

Factors to consider:

  • Current price 37.0% below estimated low
  • Earnings for 6 months up through Q2 are close to our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [0.42$, 1.09$]
  • 2024-12-30 to 2025-12-30 estimated range: [0.36$, 0.95$]

Financial Metrics affecting the NWBO estimates:

  • Negative: Non-GAAP EPS, $ of -0.06 <= 0.10
  • Negative: Operating profit margin, % of -96.64 <= 1.03
  • Negative: Operating cash flow per share per price, % of -6.04 <= 2.35
  • Negative: negative Net income

Similar symbols

Short-term NWBO quotes

Long-term NWBO plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $1.00MM $1.68MM $1.93MM
Operating Expenses $53.71MM $68.86MM $57.44MM
Operating Income $-52.70MM $-67.18MM $-55.51MM
Non-Operating Income $231.83MM $-37.85MM $-7.09MM
Interest Expense $5.01MM $6.07MM $5.24MM
R&D Expense $20.31MM $35.51MM $27.73MM
Income(Loss) $179.13MM $-105.03MM $-62.60MM
Taxes $0.00MM $31.82MM $0.00MM
Profit(Loss) $179.13MM $-136.85MM $-62.60MM
Stockholders Equity $-123.99MM $-128.10MM $-65.77MM
Assets $40.16MM $31.32MM $27.86MM
Operating Cash Flow $-38.30MM $-52.77MM $-53.64MM
Capital expenditure $6.01MM $2.90MM $3.44MM
Investing Cash Flow $-6.01MM $-2.90MM $-3.44MM
Financing Cash Flow $48.13MM $41.97MM $52.76MM
Earnings Per Share* $0.21 $-0.13 $-0.06

* EPS are Split Adjusted, recent splits may be reflected with a delay.